Biomedical nanotechnology for active drug delivery systems by applying sugar-chain molecular functions

Current Applied Physics

Volumn 5, Issue 2, 2005, Pages 112-117

  Yamazaki, Noburu ^a   Kojima, Shuji ^b   Yokoyama, Hiroshi ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Active targeting; DDS; Lectins; Ligands; Liposomes; Nanoparticles; Sugar chains

Indexed keywords

BINDING ENERGY; BIOASSAY; BIOLOGICAL MEMBRANES; CONTROLLED DRUG DELIVERY; DISSOCIATION; MOLECULAR STRUCTURE; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; PROTEINS; SUGARS; SURFACE STRUCTURE; TUMORS;

ACTIVE TARGETING; BIOMEDICAL NANOTECHNOLOGY; DRUG DELIVERY SYSTEMS (DDS); GLYCOPROTEIN; LECTINS; LIPOSOME CONJUGATES; SUGAR CHAIN LIGANDS; SUGAR CHAIN MOLECULAR FUNCTIONS;

BIOMEDICAL ENGINEERING;

EID: 10244253914     PISSN: 15671739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cap.2004.06.017     Document Type: Article

References (11)

1. S.P. Vyas, A. Singh, V. Sihorkar, Crit. Rev. Ther. Drug Carrier Syst. 18 (2001) 1.
2. N. Yamazaki, Y. Jigami, H.-J. Gabius, S. Kojima, Trends Glycosci. Glycotechnol. 13 (2001) 319.
3. S. Hurtley, R. Service, P. Szuromi, Science 291 (2001) 2337.
4. M.E. Taylor, K. Drickamer, Introduction to Glycobiology, Oxford University Press, Oxford, 2003, pp. 28-152 (Chapter 9).
5. E. Forssen, M. Willis, Adv. Drug Deliv. Res. 29 (1998) 249.
6. N. Yamazaki, J. Membrane Sci. 41 (1989) 249.
7. N. Yamazaki, M. Kodama, H.-J. Gabius, Methods Enzymol. 242 (1994) 56.
8. S. Kojima, H.-J. Gabius, J. Cancer Res. Clin. Oncol. 114 (1988) 468.
9. E.D. Green, G. Adelt, J.U. Baenziger, S. Wilson, H. Van Halbeek, J. Biol. Chem. 263 (1988) 18253.
10. M.P. Bevilacqua, S. Stengelin, M.A. Gimbrone Jr., B. Seed, Science 243 (1989) 1160.
11. J. Bischoff, J. Clin. Invest. 99 (1997) 373.